ERBB2 and breast cancer: Genomic studies have identified four different breast cancer intrinsic subtypes showing differences in their molecular expression profile and clinicopathological characteristics: luminal A, luminal B, HER2-enriched, and triple-negative subgroups [29] (Figure 2).